BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 12682292)

  • 1. Filamin-A fragment localizes to the nucleus to regulate androgen receptor and coactivator functions.
    Loy CJ; Sim KS; Yong EL
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4562-7. PubMed ID: 12682292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of filamin A with the insulin receptor alters insulin-dependent activation of the mitogen-activated protein kinase pathway.
    He HJ; Kole S; Kwon YK; Crow MT; Bernier M
    J Biol Chem; 2003 Jul; 278(29):27096-104. PubMed ID: 12734206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 90 kDa fragment of filamin A promotes Casodex-induced growth inhibition in Casodex-resistant androgen receptor positive C4-2 prostate cancer cells.
    Wang Y; Kreisberg JI; Bedolla RG; Mikhailova M; deVere White RW; Ghosh PM
    Oncogene; 2007 Sep; 26(41):6061-70. PubMed ID: 17420725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases.
    Bedolla RG; Wang Y; Asuncion A; Chamie K; Siddiqui S; Mudryj MM; Prihoda TJ; Siddiqui J; Chinnaiyan AM; Mehra R; de Vere White RW; Ghosh PM
    Clin Cancer Res; 2009 Feb; 15(3):788-96. PubMed ID: 19188148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen-induced cell migration: role of androgen receptor/filamin A association.
    Castoria G; D'Amato L; Ciociola A; Giovannelli P; Giraldi T; Sepe L; Paolella G; Barone MV; Migliaccio A; Auricchio F
    PLoS One; 2011 Feb; 6(2):e17218. PubMed ID: 21359179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human androgen receptor mutation disrupts ternary interactions between ligand, receptor domains, and the coactivator TIF2 (transcription intermediary factor 2).
    Lim J; Ghadessy FJ; Abdullah AA; Pinsky L; Trifiro M; Yong EL
    Mol Endocrinol; 2000 Aug; 14(8):1187-97. PubMed ID: 10935543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of filamin A functions.
    Nakamura F; Osborn TM; Hartemink CA; Hartwig JH; Stossel TP
    J Cell Biol; 2007 Dec; 179(5):1011-25. PubMed ID: 18056414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ca2+ and calmodulin regulate the binding of filamin A to actin filaments.
    Nakamura F; Hartwig JH; Stossel TP; Szymanski PT
    J Biol Chem; 2005 Sep; 280(37):32426-33. PubMed ID: 16030015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the androgen receptor/filamin a complex in stromal cells.
    Giovannelli P; Di Donato M; Auricchio F; Castoria G
    Methods Mol Biol; 2014; 1204():109-21. PubMed ID: 25182765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor nuclear translocation is facilitated by the f-actin cross-linking protein filamin.
    Ozanne DM; Brady ME; Cook S; Gaughan L; Neal DE; Robson CN
    Mol Endocrinol; 2000 Oct; 14(10):1618-26. PubMed ID: 11043577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperative regulation of extracellular signal-regulated kinase activation and cell shape change by filamin A and beta-arrestins.
    Scott MG; Pierotti V; Storez H; Lindberg E; Thuret A; Muntaner O; Labbé-Jullié C; Pitcher JA; Marullo S
    Mol Cell Biol; 2006 May; 26(9):3432-45. PubMed ID: 16611986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform.
    Alen P; Claessens F; Schoenmakers E; Swinnen JV; Verhoeven G; Rombauts W; Peeters B
    Mol Endocrinol; 1999 Jan; 13(1):117-28. PubMed ID: 9892017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supervillin associates with androgen receptor and modulates its transcriptional activity.
    Ting HJ; Yeh S; Nishimura K; Chang C
    Proc Natl Acad Sci U S A; 2002 Jan; 99(2):661-6. PubMed ID: 11792840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXC1 transcriptional regulatory activity is impaired by PBX1 in a filamin A-mediated manner.
    Berry FB; O'Neill MA; Coca-Prados M; Walter MA
    Mol Cell Biol; 2005 Feb; 25(4):1415-24. PubMed ID: 15684392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C-terminal rod 2 fragment of filamin A forms a compact structure that can be extended.
    Ruskamo S; Gilbert R; Hofmann G; Jiang P; Campbell ID; Ylänne J; Pentikäinen U
    Biochem J; 2012 Sep; 446(2):261-9. PubMed ID: 22676060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand- and coactivator-mediated transactivation function (AF2) of the androgen receptor ligand-binding domain is inhibited by the cognate hinge region.
    Wang Q; Lu J; Yong EL
    J Biol Chem; 2001 Mar; 276(10):7493-9. PubMed ID: 11102454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of the androgen receptor AF-2 (activation function 2) core domain reveals functional and mechanistic differences of conserved residues compared with other nuclear receptors.
    Slagsvold T; Kraus I; Bentzen T; Palvimo J; Saatcioglu F
    Mol Endocrinol; 2000 Oct; 14(10):1603-17. PubMed ID: 11043576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer.
    McGrath MJ; Binge LC; Sriratana A; Wang H; Robinson PA; Pook D; Fedele CG; Brown S; Dyson JM; Cottle DL; Cowling BS; Niranjan B; Risbridger GP; Mitchell CA
    Cancer Res; 2013 Aug; 73(16):5066-79. PubMed ID: 23801747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2).
    Berrevoets CA; Doesburg P; Steketee K; Trapman J; Brinkmann AO
    Mol Endocrinol; 1998 Aug; 12(8):1172-83. PubMed ID: 9717843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for androgen receptor interdomain and coactivator interactions suggests a transition in nuclear receptor activation function dominance.
    He B; Gampe RT; Kole AJ; Hnat AT; Stanley TB; An G; Stewart EL; Kalman RI; Minges JT; Wilson EM
    Mol Cell; 2004 Nov; 16(3):425-38. PubMed ID: 15525515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.